Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
11,507,590
-
Share change
-
+1,458,593
-
Total reported value
-
$37,110,000
-
Price per share
-
$3.22
-
Number of holders
-
25
-
Value change
-
+$4,386,222
-
Number of buys
-
15
-
Number of sells
-
12
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q4 2017
As of 31 Dec 2017,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,507,590 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, Artal Group S.A., Redmile Group, LLC, ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., SPHERA FUNDS MANAGEMENT LTD., Clearbridge Investments, LLC, SABBY MANAGEMENT, LLC, FRANKLIN RESOURCES INC, and Opus Point Partners Management, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.